Corticosteroid-sparing effect of azelastine in the management of bronchial asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 1, 1996, Pages 122-127

  Busse, William W ^a   Middleton, Elliott ^b   Storms, William ^b   Dockhorn, Robert J ^b   Chu, Theodore J ^b   Grossman, Jay ^b   Weiler, John M ^b   Bronsky, Edwin A ^b   Mansfield, Lyndon E ^b   Bell, Thomas D ^b   Hemsworth, George R ^b   Perhach, James L ^b   D'Eletto, Thomas A ^b   Dam, Anup ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZELASTINE; BECLOMETASONE DIPROPIONATE; PLACEBO;

ADOLESCENT; ADULT; AGED; APPETITE DISORDER; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SCREENING; FATIGUE; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; XEROSTOMIA;

EID: 9044251975     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.1.8542104     Document Type: Article

References (29)

1. Chand, N., and R. D. Sofia. 1993. Novel T cell modulatory, anti-inflammatory and anti-asthma activities of azelastine (abstract). J. Allergy Clin. Immunol. 91:163.
2. Chand, N., J. Pillar, W. Diamantis, and R. D. Sofia. 1985. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes. Int. Arch. Allergy Appl. Immunol. 77:451-455.
3. 4 formation and histamine secretion by azelastine: implication for its mechanism of action. Int. Arch. Allergy Appl. Immunol. 90:67-70.
4. 4 release and production by bronchial asthmatic eosinophils. Respir. Res. 9(2):206-212.
5. Shin, M. H., F. Baroody, D. Proud, A. Kagey-Sobotka, L. M. Lichtenstein, and R. M. Naclerio. 1992. The effect of azelastine on the early allergic response. Clin. Exp. Allergy. 22:289-295.
6. Kita, H., S. Horie, Y. Okubo, D. Weiler, and G. J. Gleich. 1993. Pharmacologic modulation of eosinophil degranulation (abstract). J. Allergy Clin. Immunol. 91:332.
7. 2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukemia cell line EoL-1. Curr. Med. Res. Opin. 13:163-174.
8. Nieber, K., C. Baumgarten, R. Rathsack, J. Furkert, E. Laake, S. Muller, and G. Kunkel. 1993. Effect of azelastine on substance P content in bronchoalvelar and nasal lavage fluids of patients with allergic asthma. Clin. Exp. Allergy 23:69-71.
9. Konno, S., M. Adachi, K. Asano, S. Matsuo, K. Okamoto, and T. Takahashi. 1993. Inhibitory action of azelastine on cytokine production from human peripheral blood leukocytes in vitro. Life Sci. 53:201-206.
10. Werner, U., J. Schmidt, and I. Szelenyi. 1991. Influence of azelastine on IL-1β generation in vitro and IL-1β-induced effect in vivo. Agents Actions 32:243-247.
11. Busse, W., B. Randlev, and J. Sedgwick. 1989. The effect of azelastine on neutrophil and eosinophil generation of Superoxide. J. Allergy Clin. Immunol. 83(2):400-405.
12. Chand, N., K. Nolan, W. Diamantis, and R. D. Sofia. 1992. Inhibition of aeroallergen-induced bronchial eosinophilia by azelastine in guinea pigs. Int. Arch. Allergy Immunol. 97:229-232.
13. Werner, U., and I. Szelenyi. 1992. Measurement of MPO activity as model for detection of granulocyte infiltration in different tissues. Agents Actions 35:c101-c103.
14. Metzger, W. J., S. Ali, and S. J. Mustafa. 1991. Inhibition of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by azelastine (abstract). J. Allergy Clin. Immunol. 87(1):312.
15. Meill, E. A., D. Denmead, P. Graf, W. M. Gold, and O. L. Frick. 1990. Azelastine aerosol attenuates late-phase bronchial hyperresponsiveness in atopic dogs (abstract). J. Allergy Clin. Immunol. 85:198.
16. Rafferty, P., W. H. Ng, G. Phillips, J. Clough, M. K. Church, R. Aurich, S. Ollier, and S. T. Holgate. 1989. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic athma. J. Allergy Clin. Immunol. 84(5): 649-657.
17. Shindoh, J., S. Sugiyama, K. Takagi, T. Satake, and T. Ozawa. 1991. Recovery time course of airway hyperresponsiveness to acetylcholine after ovalbumin challenge in guinea pigs. Chest 99(5):1274-1279.
18. Chand, N., V. E. Adusumalli, K. Nolan, W. Diamantis, J. K. Wichmann, J. Pivonka, C. N. Langevin, K. K. Wong, N. Kucharczyk, and R. D. Sofia. 1993. Pharmacodynamic and pharmacokinetic studies with azelastine in the guinea pig: evidence for preferential distribution into the lung. Allergy 48:19-24.
19. Tinkelman, D. G., G. A. Bucholtz, J. P. Kemp, J. W. Koepke, L. H. Repsher, S. L. Spector, W. W. Storms, and A. Van as. 1990. Evaluation of the safety and efficacy of multiple doses of azelastine to adult patients with bronchial asthma over time. Am. Rev. Respir. Dis. 141:569-574.
20. Todoroki, I., I. Yoshizawa, Y. Kawano, and T. Noma. 1990. Suppressive effect of azelastine on the induction of Df antigen specific IL-2 responsiveness in lymphocytes from patients with bronchial asthma. Jpn. J. Allergol. 39:1509-1514.
21. Ikami, R., T. Fukutomi, H. Agata, S. Shinoda, Y. Ikami, N. Kondo, and T. Orii. 1991. Effect of azelastine on bronchial asthma complicated by atopic dermatitis. Allergy Practice 11:44-46.
22. Busse, W. W., A. F. Wilson, and I. L. Bernstein, editors. 1986. Workshop 5: assessment of efficacy. J. Allergy Clin. Immunol. 18(3):525-528.
23. Cochran, W. G., and G. M. Cox, editors. 1957. Experimental Designs, 2nd ed. John Wiley, New York.
24. SAS Institute. 1990. SAS/STAT. User's Guide. SAS Institute, Inc., Cary, NC.
25. Iman, R. L., and W. J. Conover. 1981. Rank transformation as bridge between parametric and nonparametric statistics. Am. Statistician 35:124-133.
26. Toogood, J. H. 1993. Making better - and safer - use of inhaled steroids. J. Respir. Dis. 14(2):223.
27. Ali, N. J., S. Capewell, and M. J. Ward. 1991. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46:160-164.
28. Wolthers, I. D., and S. Pedersen. 1992. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. Pediatrics 89:839-842.
29. Toogood, J. H., B. Jennings, R. E. Greenway, and L. Chuang. 1980. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J. Allergy Clin. Immunol. 65:145-153.